124 related articles for article (PubMed ID: 38905461)
1. Effect of topical brinzolamide on visual function and waveform in patients of infantile nystagmus syndrome: A randomized control trial.
Yadav B; Saxena R; Dhiman R; Kochhar KP; Patil A; Sharma P; Sihota R; Tandon R
Indian J Ophthalmol; 2024 Jul; 72(7):976-982. PubMed ID: 38905461
[TBL] [Abstract][Full Text] [Related]
2. Topical brinzolamide (Azopt) versus placebo in the treatment of infantile nystagmus syndrome (INS).
Hertle RW; Yang D; Adkinson T; Reed M
Br J Ophthalmol; 2015 Apr; 99(4):471-6. PubMed ID: 25336575
[TBL] [Abstract][Full Text] [Related]
3. Effects of topical brinzolamide on infantile nystagmus syndrome waveforms: eyedrops for nystagmus.
Dell'osso LF; Hertle RW; Leigh RJ; Jacobs JB; King S; Yaniglos S
J Neuroophthalmol; 2011 Sep; 31(3):228-33. PubMed ID: 21709585
[TBL] [Abstract][Full Text] [Related]
4. Topical brinzolamide in congenital nystagmus: A retrospective study.
Nieves-Moreno M; Morales Fernández L; Domingo Gordo B; Maillo E; Diaz E; Gómez-de-Liaño R
Arch Soc Esp Oftalmol; 2017 Dec; 92(12):571-576. PubMed ID: 28734565
[TBL] [Abstract][Full Text] [Related]
5. The effects of topical carbonic anhydrase inhibitor in treatment of nystagmus.
Aygit ED; Ocak OB; İnal A; Fazıl K; Akar S; Gokyigit B
Int Ophthalmol; 2018 Feb; 38(1):265-269. PubMed ID: 28204987
[TBL] [Abstract][Full Text] [Related]
6. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification.
Kir E; Cakmak H; Dayanir V
Can J Ophthalmol; 2008 Oct; 43(5):559-62. PubMed ID: 18982032
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
8. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
March WF; Ochsner KI
Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
[TBL] [Abstract][Full Text] [Related]
9. Soft Contact Lenses to Optimize Vision in Adults with Idiopathic Infantile Nystagmus: A Pilot Parallel Randomized Controlled Trial.
Theodorou M; Quartilho A; Xing W; Bunce C; Rubin G; Adams G; Dahlmann-Noor A
Strabismus; 2018 Mar; 26(1):11-21. PubMed ID: 29333910
[TBL] [Abstract][Full Text] [Related]
10. Effects of extraocular muscle surgery on 15 patients with oculo-cutaneous albinism (OCA) and infantile nystagmus syndrome (INS).
Hertle RW; Anninger W; Yang D; Shatnawi R; Hill VM
Am J Ophthalmol; 2004 Dec; 138(6):978-87. PubMed ID: 15629289
[TBL] [Abstract][Full Text] [Related]
11. [Blurred vision after instillation of topical carbonic anhydrase inhibitor].
Ishibashi T; Mori K
Nippon Ganka Gakkai Zasshi; 2006 Sep; 110(9):689-92. PubMed ID: 17025224
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
Silver LH
Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy.
Shin D
Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S163-8. PubMed ID: 10665519
[TBL] [Abstract][Full Text] [Related]
14. Medical control of intraocular pressure after phacoemulsification.
Dayanir V; Ozcura F; Kir E; Topaloğlu A; Ozkan SB; Aktunç T
J Cataract Refract Surg; 2005 Mar; 31(3):484-8. PubMed ID: 15811735
[TBL] [Abstract][Full Text] [Related]
15. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Michaud JE; Friren B;
Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
[TBL] [Abstract][Full Text] [Related]
16. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study Group.
Silver LH
Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S147-53. PubMed ID: 10665517
[TBL] [Abstract][Full Text] [Related]
17. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
[TBL] [Abstract][Full Text] [Related]
18. Surgery for the treatment of vertical head posturing associated with infantile nystagmus syndrome: results in 24 patients.
Hertle RW; Yang D; Adams K; Caterino R
Clin Exp Ophthalmol; 2011 Jan; 39(1):37-46. PubMed ID: 20662845
[TBL] [Abstract][Full Text] [Related]
19. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
20. Effects of tenotomy on patients with infantile nystagmus syndrome: foveation improvement over a broadened visual field.
Wang Z; Dell'Osso LF; Jacobs JB; Burnstine RA; Tomsak RL
J AAPOS; 2006 Dec; 10(6):552-60. PubMed ID: 17189150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
